These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 27697670)
1. Synergistic antitumor activity of rapamycin and EF24 via increasing ROS for the treatment of gastric cancer. Chen W; Zou P; Zhao Z; Chen X; Fan X; Vinothkumar R; Cui R; Wu F; Zhang Q; Liang G; Ji J Redox Biol; 2016 Dec; 10():78-89. PubMed ID: 27697670 [TBL] [Abstract][Full Text] [Related]
2. Curcuminoid EF24 enhances the anti-tumour activity of Akt inhibitor MK-2206 through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in gastric cancer. Chen X; Dai X; Zou P; Chen W; Rajamanickam V; Feng C; Zhuge W; Qiu C; Ye Q; Zhang X; Liang G Br J Pharmacol; 2017 May; 174(10):1131-1146. PubMed ID: 28255993 [TBL] [Abstract][Full Text] [Related]
3. EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells. Zou P; Xia Y; Chen W; Chen X; Ying S; Feng Z; Chen T; Ye Q; Wang Z; Qiu C; Yang S; Liang G Oncotarget; 2016 Apr; 7(14):18050-64. PubMed ID: 26919110 [TBL] [Abstract][Full Text] [Related]
4. Impressive Suppression of Colon Cancer Growth by Triple Combination SN38/EF24/Melatonin: "Oncogenic" Bakalova R; Zhelev Z; Shibata S; Nikolova B; Aoki I; Higashi T Anticancer Res; 2017 Oct; 37(10):5449-5458. PubMed ID: 28982855 [TBL] [Abstract][Full Text] [Related]
5. A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies. Bisht S; Schlesinger M; Rupp A; Schubert R; Nolting J; Wenzel J; Holdenrieder S; Brossart P; Bendas G; Feldmann G J Nanobiotechnology; 2016 Jul; 14(1):57. PubMed ID: 27401816 [TBL] [Abstract][Full Text] [Related]
6. Auranofin induces apoptosis by ROS-mediated ER stress and mitochondrial dysfunction and displayed synergistic lethality with piperlongumine in gastric cancer. Zou P; Chen M; Ji J; Chen W; Chen X; Ying S; Zhang J; Zhang Z; Liu Z; Yang S; Liang G Oncotarget; 2015 Nov; 6(34):36505-21. PubMed ID: 26431378 [TBL] [Abstract][Full Text] [Related]
7. Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity. Subramaniam D; May R; Sureban SM; Lee KB; George R; Kuppusamy P; Ramanujam RP; Hideg K; Dieckgraefe BK; Houchen CW; Anant S Cancer Res; 2008 Mar; 68(6):1962-9. PubMed ID: 18339878 [TBL] [Abstract][Full Text] [Related]
8. Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells. He G; Feng C; Vinothkumar R; Chen W; Dai X; Chen X; Ye Q; Qiu C; Zhou H; Wang Y; Liang G; Xie Y; Wu W Cancer Chemother Pharmacol; 2016 Dec; 78(6):1151-1161. PubMed ID: 27787644 [TBL] [Abstract][Full Text] [Related]
9. Selective killing of gastric cancer cells by a small molecule targeting ROS-mediated ER stress activation. Zou P; Xia Y; Chen T; Zhang J; Wang Z; Chen W; Chen M; Kanchana K; Yang S; Liang G Mol Carcinog; 2016 Jun; 55(6):1073-86. PubMed ID: 26086416 [TBL] [Abstract][Full Text] [Related]
10. mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo. Cejka D; Preusser M; Fuereder T; Sieghart W; Werzowa J; Strommer S; Wacheck V Anticancer Res; 2008; 28(6A):3801-8. PubMed ID: 19189667 [TBL] [Abstract][Full Text] [Related]
11. Curcuminoid B63 induces ROS-mediated paraptosis-like cell death by targeting TrxR1 in gastric cells. Chen X; Chen X; Zhang X; Wang L; Cao P; Rajamanickam V; Wu C; Zhou H; Cai Y; Liang G; Wang Y Redox Biol; 2019 Feb; 21():101061. PubMed ID: 30590310 [TBL] [Abstract][Full Text] [Related]
12. Imatinib‑induced apoptosis of gastric cancer cells is mediated by endoplasmic reticulum stress. Kim JL; Lee DH; Jeong S; Kim BR; Na YJ; Park SH; Jo MJ; Jeong YA; Oh SC Oncol Rep; 2019 Mar; 41(3):1616-1626. PubMed ID: 30569109 [TBL] [Abstract][Full Text] [Related]
13. ROS generation mediates the anti-cancer effects of WZ35 via activating JNK and ER stress apoptotic pathways in gastric cancer. Zou P; Zhang J; Xia Y; Kanchana K; Guo G; Chen W; Huang Y; Wang Z; Yang S; Liang G Oncotarget; 2015 Mar; 6(8):5860-76. PubMed ID: 25714022 [TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog. Liu H; Liang Y; Wang L; Tian L; Song R; Han T; Pan S; Liu L PLoS One; 2012; 7(10):e48075. PubMed ID: 23118928 [TBL] [Abstract][Full Text] [Related]
15. Combining TRAIL and liquiritin exerts synergistic effects against human gastric cancer cells and xenograft in nude mice through potentiating apoptosis and ROS generation. Xie R; Gao CC; Yang XZ; Wu SN; Wang HG; Zhang JL; Yan W; Ma TH Biomed Pharmacother; 2017 Sep; 93():948-960. PubMed ID: 28715876 [TBL] [Abstract][Full Text] [Related]
16. The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo. Yang CH; Yue J; Sims M; Pfeffer LM PLoS One; 2013; 8(8):e71130. PubMed ID: 23940701 [TBL] [Abstract][Full Text] [Related]
17. Curcuminoid WZ35 synergize with cisplatin by inducing ROS production and inhibiting TrxR1 activity in gastric cancer cells. He W; Xia Y; Cao P; Hong L; Zhang T; Shen X; Zheng P; Shen H; Liang G; Zou P J Exp Clin Cancer Res; 2019 May; 38(1):207. PubMed ID: 31113439 [TBL] [Abstract][Full Text] [Related]
18. Biological Effects of EF24, a Curcumin Derivative, Alone or Combined with Mitotane in Adrenocortical Tumor Cell Lines. Bertazza L; Barollo S; Mari ME; Faccio I; Zorzan M; Redaelli M; Rubin B; Armanini D; Mian C; Pezzani R Molecules; 2019 Jun; 24(12):. PubMed ID: 31212829 [TBL] [Abstract][Full Text] [Related]
19. Activation of the p38 pathway by a novel monoketone curcumin analog, EF24, suggests a potential combination strategy. Thomas SL; Zhao J; Li Z; Lou B; Du Y; Purcell J; Snyder JP; Khuri FR; Liotta D; Fu H Biochem Pharmacol; 2010 Nov; 80(9):1309-16. PubMed ID: 20615389 [TBL] [Abstract][Full Text] [Related]
20. Selective killing of gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activation. Chen W; Zou P; Zhao Z; Weng Q; Chen X; Ying S; Ye Q; Wang Z; Ji J; Liang G Oncotarget; 2016 Mar; 7(13):16593-609. PubMed ID: 26919094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]